Association between cytokines and psychiatric symptoms in chronic fatigue syndrome and healthy controls

References

• Brurberg KG, Fonhus MS, Larun L, et al. Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review. BMJ Open. 2014;4(2):e003973.
   PubMed Web of Science ®Google Scholar
• Crawley E. The epidemiology of chronic fatigue syndrome/myalgic encephalitis in children. Arch Dis Child. 2014;99(2):171–174.
   PubMed Web of Science ®Google Scholar
• Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121(2):953–959.
   PubMedGoogle Scholar
• Johnston S, Brenu EW, Staines DR, et al. The adoption of chronic fatigue syndrome/myalgic encephalomyelitis case definitions to assess prevalence: a systematic review. Ann Epidemiol. 2013;23(6):371–376.
   PubMed Web of Science ®Google Scholar
• Lindal E, Stefansson JG, Bergmann S. The prevalence of chronic fatigue syndrome in Iceland – a national comparison by gender drawing on four different criteria. Nord J Psychiatry. 2002;56(4):273–277.
   PubMed Web of Science ®Google Scholar
• Clauw DJ. Perspectives on fatigue from the study of chronic fatigue syndrome and related conditions. PM R. 2010;2(5):414–430.
   PubMedGoogle Scholar
• Maes M, Twisk FN, Kubera M, et al. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin. J Affect Disord. 2012;136(3):933–939.
   PubMed Web of Science ®Google Scholar
• Fletcher MA, Zeng XR, Barnes Z, et al. Plasma cytokines in women with chronic fatigue syndrome. J Transl Med. 2009;7:96.
   PubMed Web of Science ®Google Scholar
• Broderick G, Fuite J, Kreitz A, et al. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun. 2010;24(7):1209–1217.
   PubMed Web of Science ®Google Scholar
• Torres-Harding S, Sorenson M, Jason LA, et al. Evidence for T-helper 2 shift and association with illness parameters in chronic fatigue syndrome (CFS). Bull IACFS ME. 2008;16(3):19–33.
   PubMedGoogle Scholar
• ter Wolbeek M, van Doornen LJ, Kavelaars A, et al. Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents. Brain Behav Immun. 2007;21(8):1063–1074.
   PubMed Web of Science ®Google Scholar
• Buchwald D, Wener MH, Pearlman T, et al. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J Rheumatol. 1997;24(2):372–376.
   PubMed Web of Science ®Google Scholar
• Andratsch M, Mair N, Constantin CE, et al. A key role for gp130 expressed on peripheral sensory nerves in pathological pain. J Neurosci. 2009;29(43):13473–13483. 28
   PubMed Web of Science ®Google Scholar
• Uceyler N, Schafers M, Sommer C. Mode of action of cytokines on nociceptive neurons. Exp Brain Res. 2009;196(1):67–78.
   PubMed Web of Science ®Google Scholar
• Vollmer-Conna U, Cameron B, Hadzi-Pavlovic D, et al. Postinfective fatigue syndrome is not associated with altered cytokine production. Clin Infect Dis. 2007;45(6):732–735.
   PubMed Web of Science ®Google Scholar
• Morris G, Maes M. A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome. Metab Brain Dis. 2013;28(4):523–540.
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457.
   PubMed Web of Science ®Google Scholar
• Ekinci O, Ekinci A. The connections among suicidal behavior, lipid profile and low-grade inflammation in patients with major depressive disorder: a specific relationship with the neutrophil-to-lymphocyte ratio. Nord J Psychiatry. 2017;71(8):574–580.
   PubMed Web of Science ®Google Scholar
• Milrad SF, Hall DL, Jutagir DR, et al. Depression, evening salivary cortisol and inflammation in chronic fatigue syndrome: a psychoneuroendocrinological structural regression model. Int J Psychophysiol. 2018, doi:10.1016/j.ijpsycho.2017.09.009.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160–172.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370.
   PubMed Web of Science ®Google Scholar
• Bjelland I, Dahl AA, Haug TT, et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77.
   PubMed Web of Science ®Google Scholar
• Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147–153.
   PubMed Web of Science ®Google Scholar
• Loge JH, Ekeberg O, Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J Psychosom Res. 1998;45(1):53–65.
   PubMed Web of Science ®Google Scholar
• Cleeland CS. Pain assessment in cancer. In: Osoba D, editor. Effect of cancer on quality of life. Boca Raton: CRC Press; 1991. p. 293–305.
   Google Scholar
• Klepstad P, Loge JH, Borchgrevink PC, et al. The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage. 2002;24(5):517–525.
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry. 1976;128:280–289.
   PubMed Web of Science ®Google Scholar
• Nas K, Cevik R, Batum S, et al. Immunologic and psychosocial status in chronic fatigue syndrome. Bratisl Lek Listy. 2011;112(4):208–212.
   PubMed Web of Science ®Google Scholar
• Moss RB, Mercandetti A, Vojdani A. TNF-alpha and chronic fatigue syndrome. J Clin Immunol. 1999;19(5):314–316.
   PubMed Web of Science ®Google Scholar
• Wyller VB, Sorensen O, Sulheim D, et al. Plasma cytokine expression in adolescent chronic fatigue syndrome. Brain Behav Immun. 2015;46:80–86.
   PubMed Web of Science ®Google Scholar
• Dantzer R, O’Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56.
   PubMed Web of Science ®Google Scholar
• Hestad KA, Tonseth S, Stoen CD, et al. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT. 2003;19(4):183–188.
   PubMed Web of Science ®Google Scholar
• Dahl J, Ormstad H, Aass HC, et al. Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels. Acta Psychiatr Scand. 2016;134(1):40–47.
   PubMed Web of Science ®Google Scholar
• Hestad KA, Aukrust P, Tonseth S, et al. Depression has a strong relationship to alterations in the immune, endocrine and neural system. CPSR. 2009;5:287–297.
   Google Scholar
• Bo SH, Davidsen EM, Gulbrandsen P, et al. Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia. 2009;29(3):365–372.
   PubMed Web of Science ®Google Scholar
• Rothermundt M, Arolt V, Weitzsch C, et al. Production of cytokines in acute schizophrenic psychosis. Biol Psychiatry. 1996;40(12):1294–1297.
   PubMed Web of Science ®Google Scholar
• Borovcanin M, Jovanovic I, Radosavljevic G, et al. Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse. J Psychiatr Res. 2012;46(11):1421–1426.
   PubMed Web of Science ®Google Scholar
• Simsek S, Yildirim V, Cim A, et al. Serum IL-4 and IL-10 levels correlate with the symptoms of the drug-naive adolescents with first episode, early onset schizophrenia. J Child Adolesc Psychopharmacol. 2016;26(8):721–726.
   PubMed Web of Science ®Google Scholar
• Guo J, Liu C, Wang Y, et al. Role of T helper lymphokines in the immune-inflammatory pathophysiology of schizophrenia: systematic review and meta-analysis. Nordic Journal of Psychiatry. 2015;69(5):364–372.
   PubMed Web of Science ®Google Scholar
• Meyer U, Feldon J, Schedlowski M, et al. Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun. 2006;20(4):378–388.
   PubMed Web of Science ®Google Scholar
• Stuart MJ, Baune BT. Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies. Neurosci Biobehav Rev. 2014;42:93–115.
   PubMed Web of Science ®Google Scholar